Purple Biotech Ltd
PPBT
$1.50
$0.010.33%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.14% | 12.32% | -19.92% | -34.71% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -43.64% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 23.10% | 25.69% | -16.70% | -21.90% | |
| Total Current Assets | 4.39% | 10.75% | -19.72% | -34.09% | |
|
|
|||||
| Total Current Assets | 4.39% | 10.75% | -19.72% | -34.09% | |
| Net Property, Plant & Equipment | -3.14% | 20.14% | -37.88% | -43.17% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -73.57% | -73.57% | 0.00% | -0.72% | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | -- | -- | -- | |
| Total Assets | -58.79% | -52.56% | -4.68% | -10.71% | |
|
|
|||||
| Total Accounts Payable | -27.20% | 42.27% | -78.01% | -75.04% | |
| Total Accrued Expenses | -18.87% | 14.42% | -46.39% | -52.09% | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 30.10% | 33.33% | -43.41% | -26.34% | |
| Total Finance Division Other Current Liabilities | -14.23% | 253.87% | -75.71% | -79.91% | |
| Total Other Current Liabilities | -14.23% | 253.87% | -75.71% | -79.91% | |
| Total Current Liabilities | -18.55% | 94.46% | -66.16% | -67.59% | |
|
|
|||||
| Total Current Liabilities | -18.55% | 94.46% | -66.16% | -67.59% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 21.43% | 14.29% | -0.71% | -0.71% | |
| Total Liabilities | -16.14% | 91.74% | -65.18% | -66.96% | |
|
|
|||||
| Common Stock & APIC | 4.01% | 3.29% | 10.49% | 10.65% | |
| Retained Earnings | -16.75% | -18.24% | -1.82% | -2.78% | |
| Treasury Stock & Other | -4.41% | -5.39% | -23.91% | -22.53% | |
| Total Common Equity | -61.66% | -70.44% | 9.17% | 5.25% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -61.66% | -70.44% | 9.17% | 5.25% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -231.82% | -207.84% | -27.87% | -32.39% | |
| Total Equity | -61.89% | -70.65% | 9.10% | 5.16% | |
|
|
|||||